Argireline is the trade name for acetyl hexapeptide-8, a six-amino-acid peptide marketed for the appearance of expression lines — the forehead and around-eye creases that deepen with movement. You will often see it described as “topical Botox” in advertising. That phrase is marketing shorthand, not a medical equivalence: Argireline is a cosmetic that sits on and within the skin's surface layers, not an injectable, and it is not a drug.
The cosmetic science
The interest in Argireline traces to a cosmetic study in which a topical acetyl hexapeptide solution was associated with a measurable reduction in the appearance of wrinkle depth versus baseline (Blanes-Mira et al., Int. J. Cosmet. Sci. 2002). Independent results vary, and topical peptides face the basic challenge of penetration — but as a gentle, well-tolerated ingredient it has become a routine part of “expression-line” serums.
How to use Argireline
- Apply to clean skin, focusing on areas of expression movement.
- Use once or twice daily and be consistent.
- Layer under moisturiser; wear sunscreen every morning.
Argireline pairs well with matrikine peptides like Matrixyl and with humectants such as hyaluronic acid. It is a sensible option for people who want a gentle, needle-free addition to a routine.
Setting expectations
Any effect is cosmetic and gradual, and it fades when you stop using the product. Judge it over 8–12 weeks on the look of your skin. It is not a substitute for, or equivalent to, any medical procedure.